NVO - Beaten Down COVID-19 Vaccine Partner Stock Catalent Finalizes Deal With Activist Investor Reports Mixed Q4 Earnings | Benzinga
Catalent Inc (NYSE: CTLT), valued at around $8 billion, has finalized a deal with activist investor Elliott Investment Management.
The board has recommended and approved the appointment of four new independent directors. With these appointments, Catalent's Board of Directors will consist of 16 directors, 13 of whom are independent.
Catalent's board has also established a new Strategic and Operational Review Committee to review the company's business, strategy, operations, and capital allocation priorities.
Catalent reported Q4 adjusted EPS of $0.09, missing the consensus of $0.10, with sales of $1.07 billion, down 17% Y/Y, slightly above the consensus of $1.05 billion.
The company forecasts FY24 sales of $4.30 billion-$4.50 billion versus ...